Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer
Clinical trial NCT03102047 · COMPLETED
Trial details
- NCT number
- NCT03102047
- Sponsor
- NSABP Foundation Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-14
- Primary completion
- 2021-02-22
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.